AI Chatbot for Prediabetes

MK
Overseen ByMegha K Shah, M.D., M.Sc.
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Emory University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study is testing an artificial intelligence (AI) chatbot designed to help adults at risk for type 2 diabetes adopt healthier lifestyles. The chatbot provides personalized and culturally tailored guidance on nutrition, physical activity, resistance training, and goal setting. About 30 adults aged 18 to 55 years will use the chatbot for 6 weeks and provide feedback through surveys and interviews.

Researchers will evaluate whether the chatbot is easy to use, helpful, and trustworthy, and whether data about changes in health behaviors can be feasibly collected, in order to inform larger future studies to improve diabetes prevention.

Who Is on the Research Team?

MS

Megha Shah, M.D., M.Sc.

Principal Investigator

Emory University

Are You a Good Fit for This Trial?

This trial is for adults aged 18 to 55 who are at risk for type 2 diabetes or have prediabetes. Participants should be willing to use a chatbot and provide feedback about their experience.

Inclusion Criteria

Have at least one diabetes risk factor: Family history of type 2 diabetes in first-degree relatives
Have at least one diabetes risk factor: HbA1C of 5.7-6.4%
Have at least one diabetes risk factor: BMI of 18.5 - 24.9 kg/m^2
See 9 more

Exclusion Criteria

I have been diagnosed with heart or blood vessel disease.
Are enrolled in another research study or participating in a structured lifestyle program
Are pregnant or planning to be pregnant
See 5 more

What Are the Treatments Tested in This Trial?

Interventions

  • AI-Powered Diabetes Prevention Chatbot

Trial Overview

The study tests an AI-powered chatbot that gives personalized advice on healthy eating, exercise, resistance training, and setting goals. About 30 people will use the chatbot for six weeks and share their experiences through surveys and interviews.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: AI-Powered Diabetes Prevention ChatbotExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Emory University

Lead Sponsor

Trials
1,735
Recruited
2,605,000+

Georgia Center for Diabetes Translation Research

Collaborator

Trials
5
Recruited
200+